383 related articles for article (PubMed ID: 35771627)
1. Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives.
Yu Z; Zhou X; Wang X
Cancer Res; 2022 Sep; 82(17):2955-2963. PubMed ID: 35771627
[TBL] [Abstract][Full Text] [Related]
2. From the (Epi)Genome to Metabolism and Vice Versa; Examples from Hematologic Malignancy.
Karagianni P; Giannouli S; Voulgarelis M
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204821
[TBL] [Abstract][Full Text] [Related]
3. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.
Dębek S; Juszczyński P
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated metabolism contributes to oncogenesis.
Hirschey MD; DeBerardinis RJ; Diehl AME; Drew JE; Frezza C; Green MF; Jones LW; Ko YH; Le A; Lea MA; Locasale JW; Longo VD; Lyssiotis CA; McDonnell E; Mehrmohamadi M; Michelotti G; Muralidhar V; Murphy MP; Pedersen PL; Poore B; Raffaghello L; Rathmell JC; Sivanand S; Vander Heiden MG; Wellen KE;
Semin Cancer Biol; 2015 Dec; 35 Suppl():S129-S150. PubMed ID: 26454069
[TBL] [Abstract][Full Text] [Related]
5. Metabolic plasticity of cancer cells.
Raudenská M; Peltanová B; Hönigová K; Navrátil J; Masařík M
Klin Onkol; 2022; 35(3):195-207. PubMed ID: 35760572
[TBL] [Abstract][Full Text] [Related]
6. Metabolic control of cancer progression as novel targets for therapy.
Talukdar S; Emdad L; Gogna R; Das SK; Fisher PB
Adv Cancer Res; 2021; 152():103-177. PubMed ID: 34353436
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities.
Ge T; Gu X; Jia R; Ge S; Chai P; Zhuang A; Fan X
Cancer Commun (Lond); 2022 Nov; 42(11):1049-1082. PubMed ID: 36266736
[TBL] [Abstract][Full Text] [Related]
8. Detection, mechanisms, and therapeutic implications of oncometabolites.
Cai Y; Wang Z; Guo S; Lin C; Yao H; Yang Q; Wang Y; Yu X; He X; Sun W; Qiu S; Guo Y; Tang S; Xie Y; Zhang A
Trends Endocrinol Metab; 2023 Dec; 34(12):849-861. PubMed ID: 37739878
[TBL] [Abstract][Full Text] [Related]
9. Targeting Metabolic Pathways in Kidney Cancer: Rationale and Therapeutic Opportunities.
Hoerner CR; Miao SY; Hsieh JJ; Fan AC
Cancer J; 2020; 26(5):407-418. PubMed ID: 32947309
[TBL] [Abstract][Full Text] [Related]
10. EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis.
Yang T; You C; Meng S; Lai Z; Ai W; Zhang J
Front Cell Infect Microbiol; 2022; 12():935205. PubMed ID: 35846746
[TBL] [Abstract][Full Text] [Related]
11. mTOR Regulation of Metabolism in Hematologic Malignancies.
Mirabilii S; Ricciardi MR; Tafuri A
Cells; 2020 Feb; 9(2):. PubMed ID: 32053876
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming: a hallmark of viral oncogenesis.
Lévy P; Bartosch B
Oncogene; 2016 Aug; 35(32):4155-64. PubMed ID: 26686092
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Hallmarks of Cancer Metabolism.
Pavlova NN; Thompson CB
Cell Metab; 2016 Jan; 23(1):27-47. PubMed ID: 26771115
[TBL] [Abstract][Full Text] [Related]
14. Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells.
Yang Y; Huangfu L; Li H; Yang D
Int J Hyperthermia; 2023; 40(1):2270654. PubMed ID: 37871910
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Metabolism: Yin and Yang for Tumor Progression.
Valcarcel-Jimenez L; Gaude E; Torrano V; Frezza C; Carracedo A
Trends Endocrinol Metab; 2017 Oct; 28(10):748-757. PubMed ID: 28938972
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria: The metabolic switch of cellular oncogenic transformation.
Tan YQ; Zhang X; Zhang S; Zhu T; Garg M; Lobie PE; Pandey V
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188534. PubMed ID: 33794332
[TBL] [Abstract][Full Text] [Related]
17. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.
Zhang Y; Meng Q; Sun Q; Xu ZX; Zhou H; Wang Y
Mol Metab; 2021 Feb; 44():101131. PubMed ID: 33278637
[TBL] [Abstract][Full Text] [Related]
18. The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells.
Menendez JA; Joven J; Cufí S; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; López-Bonet E; Alarcón T; Vazquez-Martin A
Cell Cycle; 2013 Apr; 12(8):1166-79. PubMed ID: 23549172
[TBL] [Abstract][Full Text] [Related]
19. Autophagy, stress, and cancer metabolism: what doesn't kill you makes you stronger.
Mathew R; White E
Cold Spring Harb Symp Quant Biol; 2011; 76():389-96. PubMed ID: 22442109
[TBL] [Abstract][Full Text] [Related]
20. The metabolic alterations of cancer cells.
Sciacovelli M; Gaude E; Hilvo M; Frezza C
Methods Enzymol; 2014; 542():1-23. PubMed ID: 24862258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
